Business Context and Reporting Period
This Form 8-K reports on the 2021 Annual Meeting of Stockholders held by Black Diamond Therapeutics, Inc. on June 18, 2021. The meeting was conducted in a virtual-only format. As of the record date (April 21, 2021), there were 36,160,247 shares of Common Stock outstanding, with 31,070,743 shares present or represented by proxy, establishing a quorum.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
Two proposals were submitted to stockholders, both of which were approved:
- Proposal No. 1 (Election of Directors): Three Class I director nominees were elected to serve until the 2024 annual meeting.
- Alexander Mayweg: 22,107,755 votes FOR; 6,309,375 votes WITHHELD.
- Rajeev Shah: 24,072,010 votes FOR; 4,345,120 votes WITHHELD.
- Robert A. Ingram: 27,047,123 votes FOR; 1,370,007 votes WITHHELD.
- Proposal No. 2 (Ratification of Auditors): The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021, was ratified.
- Results: 31,062,309 votes FOR; 2,505 votes AGAINST; 5,929 votes ABSTAIN.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the reporting of the voting outcomes.
Key Facts for Investor Verification
- Verify the tenure of the newly elected Class I directors (Alexander Mayweg, Rajeev Shah, and Robert A. Ingram) through the 2024 annual meeting.
- Confirm the engagement of PricewaterhouseCoopers LLP for the fiscal year ending December 31, 2021.
- Note the significant number of broker non-votes (2,653,613) recorded for the director elections.
- Review the definitive proxy statement filed on April 27, 2021, for detailed background on the nominees and auditor selection.